{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:10:54Z","timestamp":1788541854857,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-06040-3","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T07:49:19Z","timestamp":1752306559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Peng","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maofu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"3","key":"6040_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2016;374(3):254\u201362.","journal-title":"N Engl J Med"},{"issue":"7","key":"6040_CR2","first-page":"675","volume":"390","author":"S Snyder","year":"2024","unstructured":"Snyder S. Postmenopausal osteoporosis. N Engl J Med. 2024;390(7):675\u20136.","journal-title":"N Engl J Med"},{"key":"6040_CR3","doi-asserted-by":"crossref","unstructured":"Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, Eschweiler J, Maffulli N. Fragility fractures: risk factors and management in the elderly. Med (Kaunas) 2021, 57(10).","DOI":"10.3390\/medicina57101119"},{"issue":"1","key":"6040_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6040_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level I evidence Based - Expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105\u201319.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"9322","key":"6040_CR6","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","volume":"359","author":"PD Delmas","year":"2002","unstructured":"Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002;359(9322):2018\u201326.","journal-title":"Lancet"},{"issue":"9","key":"6040_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/13543784.2023.2263352","volume":"32","author":"F Migliorini","year":"2023","unstructured":"Migliorini F, Cocconi F, Vecchio G, Sch\u00e4efer L, Koettnitz J, Maffulli N. Pharmacological agents for bone fracture healing: talking points from recent clinical trials. Expert Opin Investig Drugs. 2023;32(9):855\u201365.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"6040_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/bmb\/ldn024","volume":"88","author":"A Khanna","year":"2008","unstructured":"Khanna A, Gougoulias N, Maffulli N. Intermittent pneumatic compression in fracture and soft-tissue injuries healing. Br Med Bull. 2008;88(1):147\u201356.","journal-title":"Br Med Bull"},{"key":"6040_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr006","volume":"100","author":"P Martinez de Albornoz","year":"2011","unstructured":"Martinez de Albornoz P, Khanna A, Longo UG, Forriol F, Maffulli N. The evidence of low-intensity pulsed ultrasound for in vitro, animal and human fracture healing. Br Med Bull. 2011;100:39\u201357.","journal-title":"Br Med Bull"},{"issue":"1","key":"6040_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12877-016-0332-0","volume":"16","author":"SM Dyer","year":"2016","unstructured":"Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. 2016;16(1):158.","journal-title":"BMC Geriatr"},{"issue":"24","key":"6040_CR11","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1001\/jama.2017.19344","volume":"318","author":"JG Zhao","year":"2017","unstructured":"Zhao JG, Zeng XT, Wang J, Liu L. Association between calcium or vitamin D supplementation and fracture incidence in Community-Dwelling older adults: A systematic review and Meta-analysis. JAMA. 2017;318(24):2466\u201382.","journal-title":"JAMA"},{"issue":"1","key":"6040_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s13018-024-05320-8","volume":"19","author":"F Huang","year":"2024","unstructured":"Huang F, Wang Y, Liu J, Cheng Y, Zhang X, Jiang H. Asperuloside alleviates osteoporosis by promoting autophagy and regulating Nrf2 activation. J Orthop Surg Res. 2024;19(1):855.","journal-title":"J Orthop Surg Res"},{"issue":"10329","key":"6040_CR13","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399(10329):1080\u201392.","journal-title":"Lancet"},{"issue":"1","key":"6040_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bmb\/ldac017","volume":"143","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a bayesian network meta-analysis. Br Med Bull. 2022;143(1):46\u201356.","journal-title":"Br Med Bull"},{"issue":"2","key":"6040_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: A living systematic review and network Meta-analysis for the American college of physicians. Ann Intern Med. 2023;176(2):182\u201395.","journal-title":"Ann Intern Med"},{"key":"6040_CR16","doi-asserted-by":"publisher","first-page":"e068033","DOI":"10.1136\/bmj-2021-068033","volume":"381","author":"MN Handel","year":"2023","unstructured":"Handel MN, Cardoso I, von Bulow C, Rohde JF, Ussing A, Nielsen SM, Christensen R, Body JJ, Brandi ML, Diez-Perez A, et al. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ. 2023;381:e068033.","journal-title":"BMJ"},{"issue":"9\u201310","key":"6040_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.phymed.2005.09.005","volume":"13","author":"ZL Wang","year":"2006","unstructured":"Wang ZL, Sun JY, Wang DN, Xie YH, Wang SW, Zhao WM. Pharmacological studies of the large-scaled purified genistein from Huaijiao (Sophora japonica-Leguminosae) on anti-osteoporosis. Phytomedicine. 2006;13(9\u201310):718\u201323.","journal-title":"Phytomedicine"},{"issue":"4","key":"6040_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/er.2001-9002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C. Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev. 2002;23(4):570\u20138.","journal-title":"Endocr Rev"},{"issue":"4","key":"6040_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1210\/er.2015-1114","volume":"38","author":"MT Drake","year":"2017","unstructured":"Drake MT, Clarke BL, Oursler MJ, Khosla S. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev. 2017;38(4):325\u201350.","journal-title":"Endocr Rev"},{"issue":"3","key":"6040_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1359\/jbmr.2003.18.3.393","volume":"18","author":"K Landin-Wilhelmsen","year":"2003","unstructured":"Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson BA. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J Bone Min Res. 2003;18(3):393\u2013405.","journal-title":"J Bone Min Res"},{"key":"6040_CR21","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.","journal-title":"BMJ"},{"issue":"11","key":"6040_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"6040_CR23","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","journal-title":"BMJ"},{"key":"6040_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"6040_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"6040_CR26","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"3","key":"6040_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/bmjebm-2022-111928","volume":"28","author":"B Sadeghirad","year":"2023","unstructured":"Sadeghirad B, Foroutan F, Zoratti MJ, Busse JW, Brignardello-Petersen R, Guyatt G, Thabane L. Theory and practice of bayesian and frequentist frameworks for network meta-analysis. BMJ Evid Based Med. 2023;28(3):204\u20139.","journal-title":"BMJ Evid Based Med"},{"issue":"12","key":"6040_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, et al. GRADE guidelines: 5. Rating the quality of evidence\u2013publication bias. J Clin Epidemiol. 2011;64(12):1277\u201382.","journal-title":"J Clin Epidemiol"},{"key":"6040_CR29","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Sch\u00fcnemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, Kessels AG, Guyatt GH. A GRADE working group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630.","journal-title":"BMJ"},{"key":"6040_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","volume":"93","author":"R Brignardello-Petersen","year":"2018","unstructured":"Brignardello-Petersen R, Bonner A, Alexander PE, Siemieniuk RA, Furukawa TA, Rochwerg B, Hazlewood GS, Alhazzani W, Mustafa RA, Murad MH, et al. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. J Clin Epidemiol. 2018;93:36\u201344.","journal-title":"J Clin Epidemiol"},{"key":"6040_CR31","doi-asserted-by":"publisher","first-page":"m3900","DOI":"10.1136\/bmj.m3900","volume":"371","author":"R Brignardello-Petersen","year":"2020","unstructured":"Brignardello-Petersen R, Florez ID, Izcovich A, Santesso N, Hazlewood G, Alhazanni W, Yepes-Nu\u00f1ez JJ, Tomlinson G, Sch\u00fcnemann HJ, Guyatt GH. GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework. BMJ. 2020;371:m3900.","journal-title":"BMJ"},{"issue":"2","key":"6040_CR32","first-page":"413","volume":"28","author":"A Cranney","year":"2001","unstructured":"Cranney A, Welch V, Wells G, Adachi J, Shea B, Simon L, Tugwell P. Discrimination of changes in osteoporosis outcomes. J Rheumatol. 2001;28(2):413\u201321.","journal-title":"J Rheumatol"},{"issue":"10434","key":"6040_CR33","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(24)00351-9","volume":"403","author":"Q Shi","year":"2024","unstructured":"Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, Chen Z, Xu S, Shen Y, Ge L, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2024;403(10434):e21\u201331.","journal-title":"Lancet"},{"key":"6040_CR34","doi-asserted-by":"publisher","first-page":"k2167","DOI":"10.1136\/bmj.k2167","volume":"361","author":"MC Magnus","year":"2018","unstructured":"Magnus MC, Miliku K, Bauer A, Engel SM, Felix JF, Jaddoe VWV, Lawlor DA, London SJ, Magnus P, McGinnis R, et al. Vitamin D and risk of pregnancy related hypertensive disorders: Mendelian randomisation study. BMJ. 2018;361:k2167.","journal-title":"BMJ"},{"issue":"3","key":"6040_CR35","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/ijms16035452","volume":"16","author":"V Conti","year":"2015","unstructured":"Conti V, Russomanno G, Corbi G, Toro G, Simeon V, Filippelli W, Ferrara N, Grimaldi M, D\u2019Argenio V, Maffulli N, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from Southern Italy. Int J Mol Sci. 2015;16(3):5452\u201366.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6040_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1186\/s13018-024-05361-z","volume":"19","author":"X Bao","year":"2024","unstructured":"Bao X, Liu C, Liu H, Wang Y, Xue P, Li Y. Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women. J Orthop Surg Res. 2024;19(1):869.","journal-title":"J Orthop Surg Res"},{"issue":"11","key":"6040_CR37","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s10067-020-04948-1","volume":"39","author":"S Kaveh","year":"2020","unstructured":"Kaveh S, Hosseinifard H, Ghadimi N, Vojdanian M, Aryankhesal A. Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis. Clin Rheumatol. 2020;39(11):3261\u201376.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"6040_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jocd.2021.11.005","volume":"25","author":"F Poutoglidou","year":"2022","unstructured":"Poutoglidou F, Samoladas E, Raikos N, Kouvelas D. Efficacy and safety of anti-sclerostin antibodies in the treatment of osteoporosis: A meta-analysis and systematic review. J Clin Densitom. 2022;25(3):401\u201315.","journal-title":"J Clin Densitom"},{"issue":"1","key":"6040_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s13018-024-05301-x","volume":"19","author":"M Andersen","year":"2024","unstructured":"Andersen M, Andresen AK, Hartvigsen J, Hermann AP, S\u00f8rensen J, Carreon LY. Vertebroplasty for painful osteoporotic vertebral compression fractures: a protocol for a single-center doubled-blind randomized sham-controlled clinical trial. VOPE2. J Orthop Surg Res. 2024;19(1):813.","journal-title":"J Orthop Surg Res"},{"issue":"8","key":"6040_CR40","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00198-024-07118-0","volume":"35","author":"T Kobayashi","year":"2024","unstructured":"Kobayashi T, Morimoto T, Ito K, Mawatari M, Shimazaki T. Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials. Osteoporos Int. 2024;35(8):1377\u201393.","journal-title":"Osteoporos Int"},{"issue":"5","key":"6040_CR41","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1210\/jc.2018-02236","volume":"104","author":"H Lyu","year":"2019","unstructured":"Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, Nigwekar SU, Leder BZ, Solomon DH. Comparison of denosumab and bisphosphonates in patients with osteoporosis: A Meta-Analysis of randomized controlled trials. J Clin Endocrinol Metab. 2019;104(5):1753\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6040_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179\u201392.","journal-title":"Nat Med"},{"issue":"1","key":"6040_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13018-021-02497-0","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Peretti GM, Tingart M, Giorgino R. Potential of biomarkers during Pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):351.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6040_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00198-024-07250-x","volume":"36","author":"A Ghaseminejad-Raeini","year":"2025","unstructured":"Ghaseminejad-Raeini A, Azarboo A, Zareshahi N, Jalali S, Fallahtafti P, Homaei A, Shirinezhad A, Hoveidaei AH. Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis. Osteoporos Int. 2025;36(1):21\u201334.","journal-title":"Osteoporos Int"},{"issue":"6937","key":"6040_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u201342.","journal-title":"Nature"},{"key":"6040_CR46","doi-asserted-by":"publisher","first-page":"1499479","DOI":"10.3389\/fendo.2024.1499479","volume":"15","author":"A Shirinezhad","year":"2024","unstructured":"Shirinezhad A, Azarboo A, Ghaseminejad-Raeini A, Kanaani Nejad F, Zareshahi N, Amiri SM, Tahmasebi Y, Hoveidaei AH. A systematic review of the association between insulin resistance surrogate indices and bone mineral density. Front Endocrinol (Lausanne). 2024;15:1499479.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"6040_CR47","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359\u201381.","journal-title":"Osteoporos Int"},{"issue":"1","key":"6040_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13018-021-02474-7","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria PG, Riccardo G. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318.","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"6040_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jbmr.3622","volume":"34","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Dinavahi RV, Lazaretti-Castro M, Ebeling PR, Adachi JD, Miyauchi A, Gielen E, Milmont CE, Libanati C, Grauer A. One year of Romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study. J Bone Min Res. 2019;34(3):419\u201328.","journal-title":"J Bone Min Res"},{"issue":"8","key":"6040_CR50","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/jbmr.3452","volume":"33","author":"MR McClung","year":"2018","unstructured":"McClung MR, Brown JP, Diez-Perez A, Resch H, Caminis J, Meisner P, Bolognese MA, Goemaere S, Bone HG, Zanchetta JR, et al. Effects of 24 months of treatment with Romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: A randomized, Double-Blind, phase 2, parallel group study. J Bone Min Res. 2018;33(8):1397\u2013406.","journal-title":"J Bone Min Res"},{"issue":"1","key":"6040_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s40200-024-01515-2","volume":"24","author":"A Shirinezhad","year":"2025","unstructured":"Shirinezhad A, Azarboo A, Mafhoumi A, Islampanah M, Mohammadi S, Ghaseminejad-Raeini A, Hoveidaei AH. Urinary pentosidine as a potential biomarker of impaired bone health: a systematic review and meta-analysis. J Diabetes Metab Disord. 2025;24(1):6.","journal-title":"J Diabetes Metab Disord"}],"updated-by":[{"DOI":"10.1186\/s13018-025-06255-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000}}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06040-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06040-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06040-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:03:10Z","timestamp":1757660590000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-06040-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6040"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06040-3","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13018-025-06255-4","asserted-by":"object"}]},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author Peng Su is untagged as corresponding author.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13018-025-06255-4","URL":"https:\/\/doi.org\/10.1186\/s13018-025-06255-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"645"}}